Class II · Moderate risk Terminated
Voriconazole Tablets
Reason cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Voriconazole Tablets 200 mg
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations
What was recalled
Voriconazole Tablets 200 mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-573-30
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- NDC code
- 68462-573-30
- Origin
- NJ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0318-2025
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Voriconazole recalls
See all
Class II · Moderate risk Ongoing
Voriconazole Tablets 50mg
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Voriconazole Container Description: voriconazole The product…
Reason CGMP Deviations
Class II · Moderate risk Terminated
Voriconazole for Oral Suspension
Reason Labeling: Incorrect or Missing Package Insert
Class II · Moderate risk Terminated
Voriconazole 10mg/Ml
Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.